According to research reviewed by Gram, a nerve block using 0.2% ropivacaine did not consistently reduce pain, pain medicine use, or recovery problems after sleeve gastrectomy in a 2026 randomized trial. Movement pain was slightly lower at 24 hours, but that difference was not statistically significant after adjustment.
According to research reviewed by Gram, a numbing injection called a nerve block did not consistently reduce pain, pain medicine use, or recovery problems after sleeve gastrectomy, a common weight-loss surgery. Researchers in a 2026 randomized trial compared patients who received 0.2% ropivacaine, a numbing medicine, with patients who received a salt water injection. Pain during movement was slightly lower at 24 hours in the numbing group, but this difference was not statistically significant after adjustment. Morphine use, nausea, recovery scores, and an inflammation marker called interleukin-8 were also similar between groups. The results suggest this type of nerve block may not offer a clear advantage for most patients, though the study has limitations.
Key Statistics
A 2026 randomized, double-blind clinical trial published in Acta Cirurgica Brasileira found that a 0.2% ropivacaine nerve block did not produce consistent differences in pain, opioid use, or recovery compared with a salt water control after sleeve gastrectomy.
In the 2026 trial of sleeve gastrectomy patients, median total morphine use was 10 mg in the ropivacaine group compared with 11 mg in the control group, a difference that was not statistically significant (p = 0.926).
The same 2026 trial reported a quality of recovery score of 118 points in both groups, with no meaningful difference between them (p = 0.717).
The Quick Take
- What they studied: Researchers wanted to know whether a numbing nerve block injected into the belly wall could reduce pain, lower pain medicine use, and speed recovery after a type of weight-loss surgery called laparoscopic sleeve gastrectomy.
- Who participated: Adults having sleeve gastrectomy surgery were enrolled. The exact number of participants was not stated in the summary provided. Participants were assigned by chance to receive either the numbing medicine or a salt water injection, and neither the patients nor the researchers knew which was given.
- Key finding: Pain during movement was slightly lower at 24 hours in the numbing group, with a median score of 1 compared with 2 in the control group on a 0 to 10 scale. However, this difference was not statistically significant after adjustment (adjusted p = 0.096). Total morphine use, nausea, and recovery scores were similar between the two groups.
- What it means for you: This study does not show that this nerve block reliably helps people recover better after weight-loss surgery. If you are preparing for this procedure, talk with your surgical team about the full range of pain control options available to you.
The Research Details
This was a randomized, double-blind clinical trial, which means participants were assigned to groups by chance. Neither the patients nor the people assessing their symptoms knew who received the active numbing medicine and who received the salt water injection. This design helps prevent expectations from shaping the results.
After patients were put to sleep for surgery in a standard way, each received an injection on both sides of the belly wall. One group received 0.2% ropivacaine, a numbing medicine that blocks pain signals from nerves in the abdominal wall. The comparison group received 0.9% saline, which is a salt water solution with no numbing effect.
Researchers tracked pain at rest and during movement, the amount of morphine given as rescue pain relief, nausea and vomiting, a patient-reported recovery score called QoR-15, discharge readiness criteria, and blood levels of inflammation markers after surgery.
The double-blind, randomized design is one of the strongest ways to test whether a treatment truly works. Because chance decided who received which injection, the two groups were likely similar at the start. Because neither side knew the assignment, differences in how people reported pain or how staff rated recovery are less likely to distort the results.
The randomized and double-blind design is a strength. However, the summary provided did not state the number of participants, so it is not possible to judge how much statistical power the study had. Several key comparisons were not statistically significant after adjusting for multiple comparisons, which is a standard correction that reduces false positive results. Readers should also keep in mind that this is a single trial, and that the journal impact factor was not verified for this review.
What the Results Show
The main pain outcome was pain during movement at 24 hours after surgery. Patients who received the numbing medicine reported a median score of 1 on a 0 to 10 scale, compared with 2 in the salt water group. The range in both groups was 0 to 6. On the surface this looks like a benefit, but the difference did not hold up after statistical adjustment, so it could be due to chance.
Pain at rest was similar between the two groups at every time point measured. This means the numbing injection did not change how much patients hurt when they were sitting or lying still.
Total morphine use was also similar, with a median of 10 mg in the numbing group and 11 mg in the control group. Nausea and vomiting after surgery, recovery quality scores, diet resumption, walking, and discharge readiness criteria were not meaningfully different between the groups.
Interleukin-8 is a protein that helps signal inflammation in the body. At a later time point, its level was numerically lower in the numbing group, with a median of 7.2 pg/mL compared with 9.8 pg/mL in the control group. This difference was not statistically significant after adjustment (adjusted p = 0.142), so it should not be taken as evidence that the block reduces inflammation.
The quality of recovery score, which asks patients how well they feel in several areas, was 118 points in both groups, with no meaningful difference (p = 0.717). This suggests the nerve block did not change how patients felt overall during early recovery.
Nerve blocks are widely used in surgery to reduce pain and the need for strong pain medicine. Results in bariatric surgery have been mixed, and many studies report benefits mainly in the first hours after surgery rather than over the full recovery period. This trial’s findings fit that mixed pattern: the numbing injection did not consistently reduce pain or opioid use. Researchers and clinicians generally look for consistent results across several well-designed trials before changing standard care, and this study adds one data point to that broader picture.
The summary provided did not state how many people took part, which makes it harder to judge how reliable the results are. Several findings were close to significance but did not pass the statistical threshold after correction, so the study may not have been large enough to detect smaller effects. The study only looked at outcomes over a limited time after surgery, so longer-term effects were not measured. The trial also tested one specific type of nerve block with one specific medicine and concentration, so the results may not apply to other nerve block techniques or other numbing medicines.
The Bottom Line
Based on this trial, there is not enough evidence to recommend this nerve block specifically for routine pain control after sleeve gastrectomy. Confidence that it provides a meaningful benefit is low, since the main pain difference was not statistically significant after adjustment. Patients and surgical teams should continue to rely on established, individualized pain plans while more research is done.
Patients scheduled for sleeve gastrectomy, surgeons, anesthesiologists, and hospital teams who design bariatric recovery protocols may find this research useful. People who are not having this type of surgery are unlikely to be affected by these findings. Anyone with a history of allergies to local anesthetics or with bleeding disorders should discuss any nerve block with their care team first.
This study measured outcomes during the first few days after surgery, mainly up to 24 hours and through discharge. It did not measure benefits or harms over weeks or months. Patients should expect that pain and recovery timelines depend heavily on the surgery itself and on their overall pain plan, not on a single injection.
Frequently Asked Questions
Does a nerve block help with pain after sleeve gastrectomy?
A 2026 randomized trial found that a 0.2% ropivacaine nerve block did not consistently reduce pain, morphine use, or recovery problems compared with a salt water control. Pain during movement was slightly lower at 24 hours, but this difference was not statistically significant after adjustment.
What is a nerve block used for during weight-loss surgery?
A nerve block is an injection of numbing medicine near nerves that carry pain signals. In this trial, it was placed in the abdominal wall to numb the area after sleeve gastrectomy. Researchers tested whether it could lower pain and pain medicine needs during recovery.
Did ropivacaine reduce inflammation after bariatric surgery?
The study measured interleukin-8, a protein linked to inflammation, and found a numerically lower level in the ropivacaine group, 7.2 pg/mL compared with 9.8 pg/mL. However, this difference was not statistically significant after adjustment, so the study does not confirm an anti-inflammatory effect.
Should I ask my surgeon about a nerve block before sleeve gastrectomy?
It is reasonable to discuss all pain control options with your surgical team before surgery. This trial did not show a consistent benefit from one specific nerve block, so your team can help decide which approach fits your health history and recovery needs.
Want to Apply This Research?
- If you are recovering from weight-loss surgery, log your pain score during walking and at rest each morning and evening on a 0 to 10 scale. Also record the number of rescue pain medicine doses you take each day. These two measures are the most direct ways to see whether your pain plan is working for you.
- Use the app to set reminders for gentle walking several times a day, as recommended by your surgical team. Track how many minutes you walk and note how your pain changes afterward. Share the log with your care team at follow-up visits so they can adjust your pain plan based on your own data.
- Continue tracking pain, medicine use, nausea, sleep, and energy levels for several weeks after surgery. Review trends weekly to spot patterns, such as pain that rises after certain activities or medicine doses that stop working. Bring the summary to every follow-up appointment and include any new symptoms, like fever or unusual swelling, so they can be checked promptly.
This article summarizes a single clinical trial for general education and is not medical advice. Pain control and recovery plans after weight-loss surgery should be decided with your surgeon and anesthesia team, based on your own health history and medications. Do not change or stop any prescribed pain medicine without talking to your care team.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.